GLEN Industries Ltd
₹108.50▼ -3.50 (-3.12%)
GLEN·BSE·Healthcare
Market Cap
261.07 Cr
PE Ratio
15.82
Volume
7,200
Day High - Low
114.50 - 108.10
52W High-Low
134.00 - 58.00
₹108.50▼ -3.50 (-3.12%)
Market Cap261.07 Cr
PE Ratio15.82
Volume7,200
Day High - Low114.50 - 108.10
52W High-Low134.00 - 58.00
GLEN Industries Ltd (GLEN): company summary
The company's annual revenue rose 22.4% to ₹203 crore, but annual net profit fell 8.3% to ₹16 crore.
GLEN Industries Ltd (GLEN) is a micro-cap Healthcare company valued at ₹261 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- GLEN Industries Ltd last traded at ₹108.5, down 3.12% on the day.
- Financial performance
- The company's annual revenue rose 22.4% to ₹203 crore, but annual net profit fell 8.3% to ₹16 crore. The latest quarter showed revenue up 24.1% to ₹108 crore, while net profit dropped 20.0% to ₹8 crore.
- Valuation multiples
- The stock trades at 15.8 times earnings, a discount to the Healthcare median of 32.0, 2.33 times book value.
- Things to watch
- The net profit margin narrowed 2.7 percentage points to 8.1%. The company's profit growth has slowed significantly in the latest quarter compared to the year-ago period. The stock is 16.4% below its 52-week high.
- Where it stands
- The company's revenue growth outpaced profit growth in both the annual and latest quarter periods. The most significant movement was the 20.0% drop in net profit in the latest quarter compared to the year-ago period.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
6.0/10
Fair
Fair Value
Sign in to see
ROE
11.82%
Average
P/E
15.82x
Fair
Debt / Equity
0.86
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
Day₹108.10
₹114.50
52W₹58.00
₹134.00
DocStoX take
Supported by growth (8.3) and momentum (7.3), but weakest on valuation (4.4).
DocStoX score
Low confidence6.0
/10
Fair
Quality
Modest
ROE 11.8%
Valuation
Rich
P/E 15.8×
Growth
Strong
Revenue +20.9% 3Y CAGR
Risk
Moderate
D/E 0.86
Momentum
Firm
66% of 52-week range
At a glance
Market Cap
₹261 Cr
52W High / Low
₹134 / ₹58
Dividend Yield
0.00%
Promoter Holding
74.30%
EPS (TTM)
₹6.86
Book Value
₹43.36
Key highlights
- Profit compounding 155% a year
- Profitable in all of the last 5 years
- Revenue compounding 21% a year
- Small ₹261 cr company — thinner liquidity
3 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore GLEN Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
GLEN Industries Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare GLEN Industries Ltd with peers
Related tools & concepts
Value GLEN Industries Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing